ReviewCell biology and toxicology2026
The influence and mechanism of gut microbiota on spermatogenesis.
Review in Cell biology and toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gut microbiota (GM) serves several functions in host, including immunological modulation, maintaining intestinal epithelial cell barrier and defending against pathogen invasion. Previous research has demonstrated that GM could regulate distal organs such as gut-brain and gut-liver axis. Recently, a rising number of researchers have discovered the substantial link between GM alteration and spermatogenesis disorder in male. This review highlights the phenomena of sperm production abnormalities caused by GM dysbiosis and the putative molecular pathways. Microbiota dysbiosis could lead to abnormal sperm production through multiple pathways. For example, the metabolic disturbance of vitamins impairs meiosis and spermatogenesis, upregulated miR-211-5p of extracellular vesicles inhibits meiosis and damages spermatogenesis, abnormal sphingolipid metabolite affects spermatogenic cell apoptosis, decreased short-chain fatty acid level causes inflammation and damages testicular tissue and reduced androgen level, resulting in spermatogenesis disorder. In addition, this review highlights therapeutic strategies, such as the administration of vitamins, probiotics, and prebiotics, for the treatment of spermatogenesis disorders associated with GM dysregulation. These insights underscore the importance of targeting the GM to preserve sperm quality and improve male reproductive health, offering promising future directions for the treatment of spermatogenic dysfunction and infertility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.